Japan’s Astellas has named Nick Eshkenazi to the new role of chief digital and transformation officer (CTDO), the first time it has included a digital role in its top mana
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh